Markets › United States › NAS › LFCR

Lifecore Biomedical Inc

NAS:LFCRHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$6.37−0.08%LiveIn session · ≈ AED 23.38 · Market cap $240.93M · Next earnings Tue 3 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	38.6%	35.1%	27.1%	32.6%	31.3%	31.4%	—	—
Operating margin	−8.7%	−10.6%	−21.1%	−6.9%	−13.4%	−1.0%	−1.0%	+0.0 pts
Net margin	−32.0%	−104.9%	−96.4%	9.4%	−30.0%	−23.8%	−23.8%	+0.0 pts
EBITDA margin	−1.0%	11.5%	−32.1%	27.8%	−6.8%	6.4%	—	—
Return on equity	−15.9%	−132.9%	2,353.7%	106.2%	−2,898.0%	216.8%	216.8%	+0.0 pts
Return on assets	−6.4%	−42.5%	−39.3%	4.7%	−16.2%	−13.3%	−13.3%	+0.0 pts
Return on capital employed	−2.2%	−12.0%	−10.2%	−4.1%	−8.2%	−0.6%	—	—
Debt / equity	1.1×	2.8×	−26.6×	11.8×	97.9×	−10.0×	−10.0×	+0.0%
Debt / assets	42.9%	90.2%	44.4%	52.6%	54.7%	61.4%	—	—
Interest coverage	−1.0×	−0.8×	−1.2×	−0.5×	−0.8×	0.0×	—	—
Current ratio	1.5×	0.7×	2.4×	2.1×	2.8×	3.5×	3.5×	+0.0%
Quick ratio	0.8×	0.5×	1.3×	1.1×	1.8×	2.3×	—	—
Cash ratio	0.0×	0.0×	0.5×	0.2×	0.3×	0.7×	0.7×	+0.0%
Asset turnover	0.2×	0.4×	0.4×	0.5×	0.5×	0.6×	—	—
Inventory turnover	1.0×	2.0×	1.8×	2.2×	2.7×	3.1×	—	—
Receivables turnover	2.4×	2.9×	3.6×	4.1×	3.0×	3.8×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—